Physician profile
Raffi E Agopian
NPI 1770584583
$6,894.64
in general payments reported to CMS, 2019-2025
18 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.08 · 2020: $29.28 · 2021: $6,031 · 2022: $291 · 2024: $203 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,925.65 | 2021 | |
| Ethicon US, LLC | $210.26 | 2019-2024 | Echelon; Endopath, Echelon Circular |
| Sanara Medtech INC. | $150.40 | 2022 | |
| Medtronic, INC. | $142.10 | 2022-2025 | Interstim |
| Acera Surgical, INC. | $133.74 | 2025 | Restrata Wound Matrix |
| Axonics, INC. | $62.57 | 2024 | Axonics |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.29 | 2019-2020 | |
| Qol Medical, LLC | $33.76 | 2025 | Sucraid |
| Palette Life Sciences, INC. | $29.62 | 2022 | |
| Genzyme Corporation | $27.71 | 2024 | |
| Innovation Technologies INC | $24.67 | 2022 | |
| Vivus LLC | $22.49 | 2025 | Pancreaze |
| Stryker Corporation | $18.16 | 2022 | |
| Karl Storz Endoscopy-America | $17.96 | 2022 | |
| Innocoll Pharmaceuticals Limited | $16.22 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $13.89 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.69 | 2019 | |
| Myriad Genetic Laboratories, INC. | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raffi Agopian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.